SAB4200190
Anti-Sumo-2/3 antibody, Rat monoclonal
clone 3H12, purified from hybridoma cell culture
登录查看公司和协议定价
所有图片(1)
别名:
Anti-HSMT3, Anti-MGC117191, Anti-SMT3 homolog 2, Anti-SMT3 suppressor of mif two 3 homolog 2, Anti-SMT3B, Anti-SMT3H2, Anti-sentrin 2, Anti-small ubiquitin-like modifier 2, Anti-small ubiquitin-related modifier 2, Anti-ubiquitin-like protein SMT3B, Monoclonal Anti-Sumo-2/3, SUMO-2/3, SUMO2/3
推荐产品
偶联物
unconjugated
抗体形式
purified from hybridoma cell culture
抗体产品类型
primary antibodies
克隆
3H12, monoclonal
形式
buffered aqueous solution
分子量
~11 kDa
种属反应性
mouse, rat, human
浓度
~1.0 mg/mL
技术
immunocytochemistry: suitable
western blot: 2-4 μg/mL using HeLa cell nuclear extract
UniProt登记号
运输
dry ice
储存温度
−20°C
靶向翻译后修饰
unmodified
基因信息
human ... SUMO3(6612)
mouse ... Sumo3(20610)
rat ... Sumo3(499417)
一般描述
Monoclonal Anti-Sumo-2/3 (rat IgG2a isotype) is derived from the hybridoma 3H12 produced by the fusion of mouse myeloma cells and splenocytes from rat immunized with a human SUMO3 fusion protein.
Small ubiquitin-like modifier 3 (SUMO3) is encoded by the gene mapped to human chromosome 21q22.3. The protein belongs to the ubiquitin-like protein family and is expressed mainly in cytoplasm.
免疫原
human SUMO3 fusion protein
应用
Monoclonal Anti-Sumo-2/3 has been used in immunoblotting and immunocytochemistry.
生化/生理作用
Small ubiquitin-like modifier (SUMO) was identified as a post-translational protein modifier.
Small ubiquitin-like modifier 3 (SUMO3) plays a vital role in enhancing cellular responses to environmental stress. It acts as a key element of the leukemogenic network in transient myeloproliferative disorder (TMD) of the newborn/acute megakaryoblastic leukaemia (AMKL).
外形
Solution in 0.01 M phosphate buffered saline, pH 7.4, containing 15 mM sodium azide
免责声明
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
闪点(°F)
Not applicable
闪点(°C)
Not applicable
法规信息
常规特殊物品
A 15q24 microdeletion in transient myeloproliferative disease (TMD) and acute megakaryoblastic leukaemia (AMKL) implicates PML and SUMO3 in the leukaemogenesis of TMD/AMKL
Haemmerling S
British Journal of Haematology, 157, 180-187 (2012)
Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3.
Saitoh H and Hinchey J.
The Journal of Biological Chemistry, 275, 6252-6258 (2000)
SUMO-2/3 conjugates accumulating under heat shock or MG132 treatment result largely from new protein synthesis.
Castoralova M
Biochimica et Biophysica Acta, 1823, 911-919 (2012)
Molecular features of human ubiquitin-like SUMO genes and their encoded proteins
Su HL and Li SS
Gene, 296, 65-73 (2002)
The Small Ubiquitin-Like Modifier (SUMO) and SUMO-Conjugating System of Chlamydomonas reinhardtii
Wang Y, et al.
Genetics, 179(1), 177-177 (2008)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门